Skip to Main Content

Paper Details

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.
70
2020
BC, HER2, HER2-E, HER2-positive (HER2+) breast cancer, HER2-positive breast cancer, HR, hormone receptor, patients, tumors
Author NameAffiliation
Tomás PascualAugust Pi i Sunyer Biomedical Research Institute, Hospital Clinic
Mothaffar F RimawiDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Charles Kent OsborneDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
Charles M PerouUniversity of North Carolina
Lisa A CareyUniversity of North Carolina
  • 1 - 5

Datasets

Release 1.2